Blogs

December 23, 2017

CFDA Greenlighted A Treatment of Chronic Heart Failure in China

The Germany-based Impulse Dynamics just announced that China’s CFDA has approved its Optimizer® system for treatment of chronic heart failure.  Impulse Dynamics’ CEO, Dr. Simos Kedikoglou noted “this is a […]
December 22, 2017

Regulatory Affairs Event with CFDA Delegates a Success!

China Med Device and CABA held a quarterly Regulatory Affairs  event with CFDA representatives from Beijing in Cambridge, MA on Sunday, December 10. Nearly 50 Regulatory representatives from U.S. Medtech […]
December 22, 2017

China Announced The World’s Second Largest Medical Device Market

According to the statistics of China Medical Device Industry Association, in 2016, the annual output value of China’s medical device industry reached 276.5 billion yuan, an increase of 13% over […]
December 21, 2017

China’s Rapid-Growing Mobile Healthcare Market: Current and Future

Mobile healthcare refers to the delivery of medical services and information through the use of mobile communication technologies. Achieve medical services “at your fingertips.” Compared with the traditional medical, mobile […]
December 20, 2017

Why Is It Taking One Year to Migrate to China’s New Medical Device Classification System?

The newly revised Medical Device Classification Catalog (hereinafter referred to as the “Classification Catalog”) released by China’s State Food and Drug Administration (CFDA) was officially released on August 31 this […]